The emerging demand for performance-enhancing peptides has spawned a significant grey market, posing both unique possibilities and real risks. These unregulated products, often sourced from foreign suppliers, bypass established pharmaceutical routes, enabling purchase at lower prices. However, the absence of quality testing and rigorous monitori… Read More